Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to large emboli which result in large cerebral vessel occlusion (LVO). This randomized control trial aims to address this unmet need by testing whether use of bilateral carotid filter implants in addition to OAC will reduce the risk of stroke in AF patients with recent (e.g. within 12 months) ischemic stroke vs. only OAC.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Documented history of clinical AF

• History of ischemic (i.e. non-hemorrhagic) stroke including symptoms of stroke resolving within 24 hours with positive neuro-imaging, meeting one of the following criteria:

• Group 1: Patient was on OAC at time of index stroke, with index stroke occurring \< 6 week from enrollment Group 2: Patient was not on OAC at time of stroke, with index stroke occurring \< 6 weeks from enrollment Group 3: Patient was on OAC at time of index stroke, with index stroke occurring 6 to 52 weeks from enrollment

• Planned use of a Vitamin K antagonist (VKA) or a direct oral anticoagulant (DOAC) for the duration of the trial

• Patient able to tolerate single antiplatelet therapy in addition to oral anticoagulation for 6 months, in the opinion of the investigator

• Bilateral ultrasound or angiogram demonstrating all of the following:

‣ Inner common carotid artery diameter range: ≥5.3 mm and ≤8.8 mm

⁃ Accessibility: up to 40 mm from skin to common carotid artery center

⁃ Implantation segment free of any atherosclerotic disease

⁃ Absence of carotid dissection or pre-existing stent(s) in common carotid artery

⁃ Absence of ≥50% stenosis of the internal carotid arteries as seen on ultrasound or angiography (CTA, MRA or DSA)

• i. For ultrasound, calculate the percentage of carotid stenosis using the Society of Radiologists in Ultrasound Consensus Criteria for Carotid Stenosis, where ≥50% stenosis is defined by internal carotid artery peak systolic velocity of ≥125 cm/sec, internal/common carotid peak systolic velocity ratio of 2 or more and end diastolic velocity of ≥40 cm/sec, or evidence of near occlusion.

• ii. For angiography, calculate the percentage of carotid stenosis using the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria (\[D - N\]/D x 100, where N is the luminal diameter at the site of maximal narrowing and D is the diameter of normal distal internal carotid artery beyond the bulb where the artery walls are parallel.

• Provision of informed consent

Locations
Other Locations
Canada
Hamilton General Hospital
RECRUITING
Hamilton
Contact Information
Primary
Sagit Broder, MSc
sagit@javelinmed.com
+972587112116
Backup
Jessica Tyrwhitt
jessica.tyrwhitt@worldhealthresearch.ca
Time Frame
Start Date: 2026-01-09
Estimated Completion Date: 2030-10-20
Participants
Target number of participants: 2000
Treatments
Experimental: Vine Filter and oral anticoagulant
Participants randomized to the intervention will undergo implantation of bilateral carotid filters and OAC therapy. In addition, participants will receive additional single antiplatelet therapy with OAC for 6 months.
No_intervention: Usual Care (oral anticoagulant only)
Participants randomized to control will not receive carotid filter implants but will receive usual care including OAC, throughout the course of the study.
Related Therapeutic Areas
Sponsors
Collaborators: World Health Research Institute
Leads: Javelin Medical

This content was sourced from clinicaltrials.gov